Enlivex Therapeutics Ltd. (ENLV) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.12
Day's range
$1.17

Enlivex Therapeutics Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARK INVESTMENT MANAGEMENT LLC 08/14/2026 2.38 M $1.31 M   279.23% 5.24%
PRELUDE CAPITAL MANAGEMENT, LLC 08/14/2026 321.31 K $176.69 K   42.34% 0.71%
BANK OF AMERICA CORP /DE/ 08/14/2026 193.15 K $106.04 K   48.12% 0.43%
TWO SIGMA INVESTMENTS, LP 08/14/2026 183.92 K $101.14 K   25.62% 0.40%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 157.65 K $86.69 K   1,428.49% 0.35%
PERSISTENT ASSET PARTNERS LTD 08/07/2026 147.88 K $81.32 K   100.00% 0.33%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 133.90 K $73.63 K   4.45% 0.29%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 129.86 K $71.41 K   61.19% 0.29%
JPMORGAN CHASE & CO 08/12/2026 121.30 K $70.35 K   -3.69% 0.27%
SIMPLEX TRADING, LLC 08/12/2026 111.41 K $61.26 K   4,160.27% 0.25%
WINTON GROUP LTD 08/07/2026 99.22 K $54.56 K   100.00% 0.22%
GOLDMAN SACHS GROUP INC 08/14/2026 89.42 K $49.17 K   -12.42% 0.20%
CITADEL ADVISORS LLC 09/02/2026 88.40 K $48.61 K   266.81% 0.19%
UBS GROUP AG 08/13/2026 73.91 K $40.65 K   -46.57% 0.16%
HRT FINANCIAL LP 08/14/2026 49.66 K $27.00 K   100.00% 0.11%
JANE STREET GROUP, LLC 08/14/2026 41.20 K $22.66 K   100.00% 0.09%
XTX TOPCO LTD 08/14/2026 21.88 K $12.03 K   -78.20% 0.05%
CHICO WEALTH RIA 08/13/2026 15.80 K $8.69 K   100.00% 0.03%
MORGAN STANLEY 08/13/2026 8.50 K $4.67 K   -91.36% 0.02%
MCGUIRE CAPITAL ADVISORS INC 08/14/2026 2.50 K $1.38 K   0.00% 0.01%
GROUP ONE TRADING, L.P. 08/14/2026 1.04 K $573   403.38% 0.00%
ACTIVEST WEALTH MANAGEMENT 07/16/2026 1.00 K $550   0.00% 0.00%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 08/13/2026 500 $275   0.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 402 $221   -65.70% 0.00%
WELLS FARGO & COMPANY/MN 08/14/2026 200 $110   -97.87% 0.00%
DARWIN WEALTH MANAGEMENT, LLC 07/21/2026 150 $82   100.00% 0.00%
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD 08/05/2026 1 $1   0.00% 0.00%
US BANCORP \DE\ 08/12/2026 0 $0   -100.00% 0.00%
HARBOUR INVESTMENTS, INC. 08/12/2026 0 $0   -100.00% 0.00%
INVESCO LTD. 08/14/2026 0 $0   -100.00% 0.00%
MILLENNIUM MANAGEMENT LLC 08/14/2026 0 $0   -100.00% 0.00%
CITADEL ADVISORS LLC 09/02/2026 0 $0   -100.00% 0.00%
TWO SIGMA SECURITIES, LLC 08/14/2026 0 $0   -100.00% 0.00%
NEUBERGER BERMAN GROUP LLC 08/13/2026 0 $0   -100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 0 $0   -100.00% 0.00%
VIRTU FINANCIAL LLC 08/13/2026 0 $0   -100.00% 0.00%
SRS CAPITAL ADVISORS, INC. 08/10/2026 0 $0   -100.00% 0.00%
DIAMETRIC CAPITAL, LP 08/14/2026 0 $0   -100.00% 0.00%
SKYVIEW INVESTMENT ADVISORS, LLC 09/15/2026 0 $0   -100.00% 0.00%
PROSPERITY CONSULTING GROUP, LLC 08/13/2026 0 $0   -100.00% 0.00%
TD WATERHOUSE CANADA INC. 07/27/2026 0 $0   -100.00% 0.00%

Enlivex Therapeutics Ltd institutional Ownership - FAQ's

During the previous two years, 42 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd. The most heavily invested institutionals were:

ARK Investment Management LLC: 2.38 M

PRELUDE CAPITAL MANAGEMENT, LLC: 321,306

BANK OF AMERICA CORP /DE/: 193,150

TWO SIGMA INVESTMENTS, LP: 183,924

SUSQUEHANNA INTERNATIONAL GROUP, LLP: 157,648

Persistent Asset Partners Ltd: 147,879

9.35% of Enlivex Therapeutics Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 4.25 M shares in the last 24 months. This purchase volume represents approximately $4.93 M in transactions.